InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-25.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Doogan Declan, Director. Insider active across 2 companies, notably Tenax Therapeutics, INC.. In total, 13 disclosures have been recorded. Breakdown: 0 buy · 6 sells. Total volume traded: €4.2m. Activity tracked since 30 June 2021. The latest transaction was disclosed on 11 August 2022 (Don). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
567,871 shares0Common StockSEC:0001654954-22-011198:0
2,464 shares@ US$67.82740.011% mcap3.3% of flowCommon SharesSEC:0001562180-22-001435:0
11,706 shares@ US$64.42210.051% mcap29.7% of flowCommon SharesSEC:0001562180-22-001434
11,706 shares@ US$64.42210.051% mcap14.9% of flowCommon SharesSEC:0001562180-22-001434:0
2,464 shares@ US$67.82743.3% of flowCommon SharesSEC:0001562180-22-001435
13,026 shares@ US$112.39960.098% mcap28.9% of flowCommon SharesSEC:0001562180-21-007370:0
13,026 shares@ US$112.399628.9% of flowCommon SharesSEC:0001562180-21-007370
250,000 shares@ US$0.610.010% mcap3.0% of flowCommon SharesSEC:0001562180-21-007138:0
250,000 shares@ US$0.613.0% of flowCommon SharesSEC:0001562180-21-007138
567,871 shares0Common StockSEC:0001654954-21-008766:0
567,871 shares0Common StockSEC:0001654954-21-008766
3,070,000 sharesCommon StockSEC:0001654954-21-006925:0
3,070,000 sharesCommon StockSEC:0001654954-21-006925
13 of 13 declarations
About Doogan Declan
Declan Doogan serves as a Director at TENAX THERAPEUTICS, INC. and Biohaven Pharmaceutical Holding Co Ltd. He brings his expertise in corporate governance and strategy, contributing to the oversight and direction of these companies' activities. His experience in the pharmaceutical sector enables him to play a crucial role in strategic decision-making.
